discuss dosing and schedule with a qualified provider
Second, we hypothesized that chronic, exogenous activation of this excitatory pathway could reverse the crossed cerebellar diaschisis, and possibly even atrophic changes, that occur following contralateral cortical ischemia and contribute to loss of function [90, 94, 120]
of this final rule with comment period, we are removing the Median Time from ED Arrival to ED Departure for Discharged ED Patients measure beginning with the CY 2028 reporting period/CY 2030 payment determination, when reporting for the Emergency Care Access & Timeliness eCQM becomes mandatory
One study utilized chitosan nanoparticles, a biocompatible and biodegradable polymer, as a carrier for doxorubicin and AOD 9604
OPPS Drug Acquisition Cost Survey Description and Burden Calculation From January 1, 2026, through March 31, 2026, we intend to survey hospitals paid under the OPPS for their drug acquisition costs, including for SCODs, and drugs and biologicals CMS historically treats as SCODs
